Evaluating two group programmes of cognitive training in mild-to-moderate AD: Is there any difference between a ‘global' stimulation and a ‘cognitive-specific' one?

By Farina E.   Mantovani F.   Fioravanti R.   Pignatti R.   Chiavari L.   Imbornone E.   Olivotto F.   Alberoni M.   Mariani C.   Nemni R.  

Aging and Mental Health, Vol. 10, Iss. 3, 2006-05 ,pp. : 211-218

Routledge Ltd

Access to resources Recommend Favorite

Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression

By Darbinyan V.   Aslanyan G.   Amroyan E.   Gabrielyan E.   Malmström C.   Panossian A.  

Nordic Journal of Psychiatry, Vol. 61, Iss. 5, 2007-01 ,pp. : 343-348

Informa Healthcare

Access to resources Recommend Favorite

Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease

By Stankovic Goran   Sparks D. Larry  

Neurological Research, Vol. 28, Iss. 6, 2006-09 ,pp. : 621-624

Maney Publishing

Access to resources Recommend Favorite

Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimer's Disease: Two Phase 3 Studies

By  

Current Alzheimer Research, Vol. 8, Iss. 5, 2011-08 ,pp. : 592-606

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol, Copper and A&bgr; in Controls, MCI, AD and the AD Cholesterol- Lowering Treatment Trial (ADCLT)

By  

Current Alzheimer Research, Vol. 2, Iss. 5, 2005-12 ,pp. : 527-539

Bentham Science Publishers

Access to resources Recommend Favorite